Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Sep;45(9):771–773. doi: 10.1136/ard.45.9.771

Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.

R A Asherson, A G Benbow, C J Speirs, N Jackson, G R Hughes
PMCID: PMC1001985  PMID: 3767464

Abstract

A patient who developed pulmonary hypertension and systemic lupus erythematosus as a complication of hydralazine therapy is reported. She was a slow acetylator and in addition was found to have a null allele at the C4A locus.

Full text

PDF
771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson N. E., Ali M. R. The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis. 1984 Oct;43(5):760–763. doi: 10.1136/ard.43.5.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asherson R. A., Mackworth-Young C. G., Boey M. L., Hull R. G., Saunders A., Gharavi A. E., Hughes G. R. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1024–1025. doi: 10.1136/bmj.287.6398.1024-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Asherson R. A., Morgan S. H., Hackett D., Montanes P., Oakley C., Hughes G. R. Rheumatoid arthritis and pulmonary hypertension. A report of three cases. J Rheumatol. 1985 Feb;12(1):154–159. [PubMed] [Google Scholar]
  4. Asherson R. A., Morgan S. H., Harris N., Gharavi A. E., Hughes G. R., Millar A. B. Pulmonary hypertension and chronic cutaneous lupus erythematosus: association with the lupus anticoagulant. Arthritis Rheum. 1985 Jan;28(1):118–118. doi: 10.1002/art.1780280121. [DOI] [PubMed] [Google Scholar]
  5. Asherson R. A., Oakley C. M. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol. 1986 Feb;13(1):1–5. [PubMed] [Google Scholar]
  6. Batchelor J. R., Welsh K. I., Tinoco R. M., Dollery C. T., Hughes G. R., Bernstein R., Ryan P., Naish P. F., Aber G. M., Bing R. F. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet. 1980 May 24;1(8178):1107–1109. doi: 10.1016/s0140-6736(80)91554-8. [DOI] [PubMed] [Google Scholar]
  7. Bernstein R. M., Asherson R. A., Oakley C. M., Hughes G. R. Anticentromere antibody and pulmonary hypertension. Arthritis Rheum. 1984 Sep;27(9):1075–1076. doi: 10.1002/art.1780270928. [DOI] [PubMed] [Google Scholar]
  8. Bernstein R. M., Egerton-Vernon J., Webster J. Hydrallazine-induced cutaneous vasculitis. Br Med J. 1980 Jan 19;280(6208):156–157. doi: 10.1136/bmj.280.6208.156-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Björck S., Westberg G., Svalander C., Mulec H. Rapidly progressive glomerulonephritis after hydralazine. Lancet. 1983 Jul 2;2(8340):42–42. doi: 10.1016/s0140-6736(83)90021-1. [DOI] [PubMed] [Google Scholar]
  10. Brentjens J., Ossi E., Albini B., Sepulveda M., Kano K., Sheffer J., Vasilion P., Marine E., Baliah T., Jockin H. Disseminated immune deposits in lupus erythematosus. Arthritis Rheum. 1977 May;20(4):962–968. doi: 10.1002/art.1780200408. [DOI] [PubMed] [Google Scholar]
  11. CALDWELL I. W., AITCHISON J. D. Pulmonary hypertension in dermatomyositis. Br Heart J. 1956 Apr;18(2):273–276. doi: 10.1136/hrt.18.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cameron H. A., Ramsay L. E. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed) 1984 Aug 18;289(6442):410–412. doi: 10.1136/bmj.289.6442.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Doherty M., Maddison P. J., Grey R. H. Hydralazine induced lupus syndrome with eye disease. Br Med J (Clin Res Ed) 1985 Mar 2;290(6469):675–675. doi: 10.1136/bmj.290.6469.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GARDNER D. L., DUTHIE J. J., MACLEOD J., ALLAN W. S. Pulmonary hypertension in rheumatoid arthritis: report of a case with intimal sclerosis of the pulmonary and digital arteries. Scott Med J. 1957 May;2(5):183–188. doi: 10.1177/003693305700200502. [DOI] [PubMed] [Google Scholar]
  15. Gladman D. D., Sternberg L. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1985 Apr;12(2):365–367. [PubMed] [Google Scholar]
  16. Hainaut P., Lavenne E., Magy J. M., Lebacq E. G. Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol. 1986 Jan;5(1):96–101. doi: 10.1007/BF02030976. [DOI] [PubMed] [Google Scholar]
  17. Harmon C. E., Portanova J. P. Drug-induced lupus: clinical and serological studies. Clin Rheum Dis. 1982 Apr;8(1):121–135. [PubMed] [Google Scholar]
  18. Haupt H. M., Moore G. W., Hutchins G. M. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med. 1981 Nov;71(5):791–798. doi: 10.1016/0002-9343(81)90366-1. [DOI] [PubMed] [Google Scholar]
  19. Hubscher O., Eimon A., Elsner B., Arana R. M. Fatal post-partum pulmonary vasculitis in systemic lupus erythematosus. Clin Rheumatol. 1984 Dec;3(4):547–550. doi: 10.1007/BF02031281. [DOI] [PubMed] [Google Scholar]
  20. Mansilla-Tinoco R., Harland S. J., Ryan P. J., Bernstein R. M., Dollery C. T., Hughes G. R., Bulpitt C. J., Morgan A., Jones J. M. Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed) 1982 Mar 27;284(6320):936–939. doi: 10.1136/bmj.284.6320.936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morrison D. A., Gay R. G., Feldshon D., Sampliner R. E. Severe pulmonary hypertension in a patient with Whipple's disease. Am J Med. 1985 Aug;79(2):263–267. doi: 10.1016/0002-9343(85)90020-8. [DOI] [PubMed] [Google Scholar]
  22. Perry H. M., Jr Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Am J Med. 1973 Jan;54(1):58–72. doi: 10.1016/0002-9343(73)90084-3. [DOI] [PubMed] [Google Scholar]
  23. Quismorio F. P., Jr, Sharma O., Koss M., Boylen T., Edmiston A. W., Thornton P. J., Tatter D. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum. 1984 May;13(4):349–359. doi: 10.1016/0049-0172(84)90015-5. [DOI] [PubMed] [Google Scholar]
  24. Sakimura K., Aizawa Y., Watanabe K., Yoshizaki T., Shibata A. [A case of Sjögren's syndrome with pulmonary hypertension, hypergammaglobulinemia and thrombocytopenia (author's transl)]. Nihon Naika Gakkai Zasshi. 1982 Jan 10;71(1):71–76. [PubMed] [Google Scholar]
  25. Salerni R., Rodnan G. P., Leon D. F., Shaver J. A. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977 Apr;86(4):394–399. doi: 10.7326/0003-4819-86-4-394. [DOI] [PubMed] [Google Scholar]
  26. Schwartzberg M., Lieberman D. H., Getzoff B., Ehrlich G. E. Systemic lupus erythematosus and pulmonary vascular hypertension. Arch Intern Med. 1984 Mar;144(3):605–607. [PubMed] [Google Scholar]
  27. Trell E., Lindström C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis. 1971 Jul;30(4):390–400. doi: 10.1136/ard.30.4.390. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES